PsyBio Therapeutics Corp
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated… Read more
Market Cap & Net Worth: PsyBio Therapeutics Corp (PSYBF)
PsyBio Therapeutics Corp (PINK:PSYBF) has a market capitalization of $8.09K ($8.09K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47870 globally and #14750 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PsyBio Therapeutics Corp's stock price $0.00 by its total outstanding shares 80851793 (80.85 Million).
PsyBio Therapeutics Corp Market Cap History: 2021 to 2025
PsyBio Therapeutics Corp's market capitalization history from 2021 to 2025. Data shows change from $12.94 Million to $8.09K (-86.84% CAGR).
PsyBio Therapeutics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PsyBio Therapeutics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of PSYBF by Market Capitalization
Companies near PsyBio Therapeutics Corp in the global market cap rankings as of March 18, 2026.
Key companies related to PsyBio Therapeutics Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
PsyBio Therapeutics Corp Historical Marketcap From 2021 to 2025
Between 2021 and today, PsyBio Therapeutics Corp's market cap moved from $12.94 Million to $ 8.09K, with a yearly change of -86.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.09K | 0.00% |
| 2024 | $8.09K | -97.73% |
| 2023 | $355.75K | -83.33% |
| 2022 | $2.13 Million | -83.50% |
| 2021 | $12.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PsyBio Therapeutics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.09K USD |
| MoneyControl | $8.09K USD |
| MarketWatch | $8.09K USD |
| marketcap.company | $8.09K USD |
| Reuters | $8.09K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.